ArticleNature communications2026
Coherent transformation of metal halide perovskites.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
Metal-halide perovskites offer high optoelectronic performance but translating laboratory efficiencies into controllable, reproducible processes remains challenging. Perovskite crystallization is tracked by in situ multiwavelength absorption to show that coherent, layer-by-layer conversion of low-n intermediates to three-dimensional perovskite, quantified by a transformation index (TI), correlates with device quality. TI displays a Sabatier-type dependence on additive-precursor interaction strength and concentration, defining an engineering window for reproducible film formation. Within this window, post-treatment-free devices reach a champion power conversion efficiency of 26.40% with improved stability and reduced device scatter at laboratory scale. TI is extractable from an inline optical readout and provides a measurable metric for additive screening and process tuning. Its applicability to scalable deposition is further validated through slot-die coated mini-modules, offering a practical pathway for inline process control.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.